OUP (Osage University Partners)
About OUP (Osage University Partners)
OUP is a venture capital fund investing in start-ups that commercialize university research.
Investment focus
Stages
Sectors
Portfolio (8 in our database)
Pionyr ImmunotherapeuticsPionyr Immunotherapeutics is a developer of cancer immunotherapies designed to target the tumor microenvironment.Corporate Round · $352M raisedReCode TherapeuticsReCode Therapeutics is a genetic medicines company developing targeted, disease-modifying therapies for life-limiting respiratory diseases.Series B · $162M raisedQ32 BioQ32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.Series B · $106M raisedArsenalBioArsenalBio is a programmable cell therapy company.Series A · $85M raisedElementary RoboticsElementary Robotics is a robotics startup that built a platform for applying machine learning to the logistics industries.Series B · $48M raisedStreetLight DataStreetLight Data is a data analytics company transforming urban planning and transportation design with the power of geospatial data.Acquired · $44M raisedKenSciKenSci offers Healthcare AI platfrom & prediction apps that work across Clinical workflows, Cost Mgmt & Hospital Ops. #DeathVsDataScience.Acquired · $31M raisedQuantum CircuitsQCI aims to develop, manufacture, and sell the first practical and useful quantum computers based on superconducting devices.Series A · $18M raised